Biodexa Pharmaceuticals PLC Unsponsored ADR (NASDAQ:BDRX – Get Free Report)’s share price rose 0.1% during mid-day trading on Tuesday . The stock traded as high as $0.94 and last traded at $0.92. Approximately 283,491 shares changed hands during mid-day trading, a decline of 74% from the average daily volume of 1,092,627 shares. The stock had previously closed at $0.92.
Biodexa Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 0.01, a current ratio of 1.75 and a quick ratio of 1.75. The firm’s fifty day moving average price is $1.24 and its 200 day moving average price is $2.65.
Biodexa Pharmaceuticals Company Profile
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.
Featured Articles
- Five stocks we like better than Biodexa Pharmaceuticals
- How Can Investors Benefit From After-Hours Trading
- 3 Hot Trades for Insiders, But Are They Good Buys for Investors?
- What does consumer price index measure?
- Why Qualcomm’s Latest Price Target Can’t Be Ignored
- Stock Sentiment Analysis: How it Works
- Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs
Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
